Drug Shortage Report for TOBRAMYCIN INJECTION, USP
| Report ID | 226 |
| Drug Identification Number | 02382814 |
| Brand name | TOBRAMYCIN INJECTION, USP |
| Common or Proper name | Tobramycin |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10VL |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2016-12-13 |
| Estimated end date | 2017-07-15 |
| Actual end date | 2017-03-13 |
| Shortage status | Resolved |
| Updated date | 2017-03-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-03-14 | French | Compare |
| v3 | 2017-03-14 | English | Compare |
| v2 | 2017-03-10 | French | Compare |
| v1 | 2017-03-10 | English | Compare |
Showing 1 to 4 of 4